Skip to main content
Top
Published in: Journal of Translational Medicine 1/2022

Open Access 01-12-2022 | Research

Development of a risk prediction model for bloodstream infection in patients with fever of unknown origin

Authors: Teng Xu, Shi Wu, Jingwen Li, Li Wang, Haihui Huang

Published in: Journal of Translational Medicine | Issue 1/2022

Login to get access

Abstract

Background

Bloodstream infection (BSI) is a significant cause of mortality among patients with fever of unknown origin (FUO). Inappropriate empiric antimicrobial therapy increases difficulty in BSI diagnosis and treatment. Knowing the risk of BSI at early stage may help improve clinical outcomes and reduce antibiotic overuse.

Methods

We constructed a multivariate prediction model based on clinical features and serum inflammatory markers using a cohort of FUO patients over a 5-year period by Least Absolute Shrinkage and Selection Operator (LASSO) and logistic regression.

Results

Among 712 FUO patients, BSI was confirmed in 55 patients. Five independent predictors available within 24 h after admission for BSI were identified: presence of diabetes mellitus, chills, C-reactive protein level of 50–100 mg/L, procalcitonin > 0.3 ng/mL, neutrophil percentage > 75%. A predictive score incorporating these 5 variables has adequate concordance with an area under the curve of 0.85. The model showed low positive predictive value (22.6%), but excellent negative predictive value (97.4%) for predicting the risk of BSI. The risk of BSI reduced to 2.0% in FUO patients if score < 1.5.

Conclusions

A simple tool based on 5 variables is useful for timely ruling out the individuals at low risk of BSI in FUO population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Timsit JF, Ruppé E, Barbier F, Tabah A, Bassetti M. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020;46:266–84.CrossRef Timsit JF, Ruppé E, Barbier F, Tabah A, Bassetti M. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020;46:266–84.CrossRef
2.
go back to reference Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19:501–9.CrossRef Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19:501–9.CrossRef
3.
go back to reference Kern WV, Rieg S. Burden of bacterial bloodstream infection—a brief update on epidemiology and significance of multidrug-resistant pathogens. Clin Microbiol Infect. 2020;26:151–7.CrossRef Kern WV, Rieg S. Burden of bacterial bloodstream infection—a brief update on epidemiology and significance of multidrug-resistant pathogens. Clin Microbiol Infect. 2020;26:151–7.CrossRef
4.
5.
go back to reference Zhou G, Zhou Y, Zhong C, et al. Retrospective analysis of 1,641 cases of classic fever of unknown origin. Ann Transl Med. 2020;8:690.CrossRef Zhou G, Zhou Y, Zhong C, et al. Retrospective analysis of 1,641 cases of classic fever of unknown origin. Ann Transl Med. 2020;8:690.CrossRef
6.
go back to reference Ingarfield SL, Celenza A, Jacobs IG, Riley TV. Outcomes in patients with an emergency department diagnosis of fever of unknown origin. Emerg Med Australas. 2007;19:105–12. Ingarfield SL, Celenza A, Jacobs IG, Riley TV. Outcomes in patients with an emergency department diagnosis of fever of unknown origin. Emerg Med Australas. 2007;19:105–12.
7.
go back to reference von Dach E, Albrich WC, Brunel AS, et al. Effect of C-reactive protein-guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: a randomized clinical trial. JAMA. 2020;323:2160–9.CrossRef von Dach E, Albrich WC, Brunel AS, et al. Effect of C-reactive protein-guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: a randomized clinical trial. JAMA. 2020;323:2160–9.CrossRef
8.
go back to reference Babady NE. Clinical metagenomics for bloodstream infections: is the juice worth the squeeze? Clin Infect Dis. 2021;72:246–8.CrossRef Babady NE. Clinical metagenomics for bloodstream infections: is the juice worth the squeeze? Clin Infect Dis. 2021;72:246–8.CrossRef
9.
go back to reference Xu T, Wang L, Wu S, Fenfen Z, Huang H. Utility of a simple scoring system in differentiating bacterial infections in cases of fever of unknown origin. Clin Infect Dis. 2020;71:409–15.CrossRef Xu T, Wang L, Wu S, Fenfen Z, Huang H. Utility of a simple scoring system in differentiating bacterial infections in cases of fever of unknown origin. Clin Infect Dis. 2020;71:409–15.CrossRef
10.
go back to reference Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.CrossRef Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.CrossRef
11.
go back to reference Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine. 1961;40:1–30.CrossRef Petersdorf RG, Beeson PB. Fever of unexplained origin: report on 100 cases. Medicine. 1961;40:1–30.CrossRef
12.
go back to reference Durack DT, Street AC. Fever of unknown origin–reexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35–51. Durack DT, Street AC. Fever of unknown origin–reexamined and redefined. Curr Clin Top Infect Dis. 1991;11:35–51.
14.
go back to reference Sullivan LM, Massaro JM, D’Agostino RB. Presentation of multivariate data for clinical use: the Framingham study risk score functions. Stat Med. 2004;23:1631–60.CrossRef Sullivan LM, Massaro JM, D’Agostino RB. Presentation of multivariate data for clinical use: the Framingham study risk score functions. Stat Med. 2004;23:1631–60.CrossRef
15.
go back to reference Fanshawe TR, Power M, Graziadio S, Ordóñez-Mena JM, Simpson J, Allen J. Interactive visualisation for interpreting diagnostic test accuracy study results. BMJ Evid Based Med. 2018;23:13–6.CrossRef Fanshawe TR, Power M, Graziadio S, Ordóñez-Mena JM, Simpson J, Allen J. Interactive visualisation for interpreting diagnostic test accuracy study results. BMJ Evid Based Med. 2018;23:13–6.CrossRef
16.
go back to reference Lee CC, Hong MY, Lee NY, Chen PL, Chang CM, Ko WC. Pitfalls in using serum C-reactive protein to predict bacteremia in febrile adults in the ED. Am J Emerg Med. 2012;30:562–9.CrossRef Lee CC, Hong MY, Lee NY, Chen PL, Chang CM, Ko WC. Pitfalls in using serum C-reactive protein to predict bacteremia in febrile adults in the ED. Am J Emerg Med. 2012;30:562–9.CrossRef
17.
go back to reference Debard AL, Vautrin C, Pariset C, Bienvenu J, Monneret G. High serum procalcitonin levels do not predict bacteremia in adult patients with acute fever. Clin Infect Dis. 2003;36:825–6.CrossRef Debard AL, Vautrin C, Pariset C, Bienvenu J, Monneret G. High serum procalcitonin levels do not predict bacteremia in adult patients with acute fever. Clin Infect Dis. 2003;36:825–6.CrossRef
18.
go back to reference Hoeboer SH, van der Geest PJ, Nieboer D, Groeneveld AB. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect. 2015;21:474–81.CrossRef Hoeboer SH, van der Geest PJ, Nieboer D, Groeneveld AB. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect. 2015;21:474–81.CrossRef
19.
go back to reference Marik PE, Stephenson E. The ability of Procalcitonin, lactate, white blood cell count and neutrophil-lymphocyte count ratio to predict blood stream infection. Analysis of a large database. J Crit Care. 2020;60:135–9.CrossRef Marik PE, Stephenson E. The ability of Procalcitonin, lactate, white blood cell count and neutrophil-lymphocyte count ratio to predict blood stream infection. Analysis of a large database. J Crit Care. 2020;60:135–9.CrossRef
20.
go back to reference Oussalah A, Ferrand J, Filhine-Tresarrieu P, et al. Diagnostic accuracy of procalcitonin for predicting blood culture results in patients with suspected bloodstream infection: an observational study of 35,343 consecutive patients (a STROBE-compliant article). Medicine. 2015;94:e1774.CrossRef Oussalah A, Ferrand J, Filhine-Tresarrieu P, et al. Diagnostic accuracy of procalcitonin for predicting blood culture results in patients with suspected bloodstream infection: an observational study of 35,343 consecutive patients (a STROBE-compliant article). Medicine. 2015;94:e1774.CrossRef
21.
go back to reference Wu Q, Yang H, Kang Y. Comparison of diagnostic accuracy among procalcitonin, C-reactive protein, and interleukin 6 for blood culture positivity in general ICU patients. Crit Care. 2018;22:339.CrossRef Wu Q, Yang H, Kang Y. Comparison of diagnostic accuracy among procalcitonin, C-reactive protein, and interleukin 6 for blood culture positivity in general ICU patients. Crit Care. 2018;22:339.CrossRef
22.
go back to reference Bassetti M, Russo A, Righi E, et al. Comparison between procalcitonin and C-reactive protein to predict blood culture results in ICU patients. Crit Care. 2018;22:252.CrossRef Bassetti M, Russo A, Righi E, et al. Comparison between procalcitonin and C-reactive protein to predict blood culture results in ICU patients. Crit Care. 2018;22:252.CrossRef
23.
go back to reference Liu CP, Liu ZY, Liu JP, Kang Y, Mao CS, Shang J. Diagnostic value of common inflammatory markers on fever of unknown origin. Jpn J Infect Dis. 2016;69:378–83.CrossRef Liu CP, Liu ZY, Liu JP, Kang Y, Mao CS, Shang J. Diagnostic value of common inflammatory markers on fever of unknown origin. Jpn J Infect Dis. 2016;69:378–83.CrossRef
24.
go back to reference Su CP, Chen TH, Chen SY, et al. Predictive model for bacteremia in adult patients with blood cultures performed at the emergency department: a preliminary report. J Microbiol Immunol Infect. 2011;44:449–55.CrossRef Su CP, Chen TH, Chen SY, et al. Predictive model for bacteremia in adult patients with blood cultures performed at the emergency department: a preliminary report. J Microbiol Immunol Infect. 2011;44:449–55.CrossRef
25.
go back to reference Ratzinger F, Haslacher H, Perkmann T, et al. Machine learning for fast identification of bacteraemia in SIRS patients treated on standard care wards: a cohort study. Sci Rep. 2018;8:12233.CrossRef Ratzinger F, Haslacher H, Perkmann T, et al. Machine learning for fast identification of bacteraemia in SIRS patients treated on standard care wards: a cohort study. Sci Rep. 2018;8:12233.CrossRef
26.
go back to reference Roimi M, Neuberger A, Shrot A, Paul M, Geffen Y, Bar-Lavie Y. Early diagnosis of bloodstream infections in the intensive care unit using machine-learning algorithms. Intensive Care Med. 2020;46:454–62.CrossRef Roimi M, Neuberger A, Shrot A, Paul M, Geffen Y, Bar-Lavie Y. Early diagnosis of bloodstream infections in the intensive care unit using machine-learning algorithms. Intensive Care Med. 2020;46:454–62.CrossRef
27.
go back to reference Mert A, Ozaras R, Tabak F, et al. Fever of unknown origin: a review of 20 patients with adult-onset Still's disease. Clin Rheumatol. 2003;22:89–93.CrossRef Mert A, Ozaras R, Tabak F, et al. Fever of unknown origin: a review of 20 patients with adult-onset Still's disease. Clin Rheumatol. 2003;22:89–93.CrossRef
28.
go back to reference Wright WF, Auwaerter PG. Fever and fever of unknown origin: review, recent advances, and lingering dogma. Open Forum Infect Dis. 2020;7:ofaa132.CrossRef Wright WF, Auwaerter PG. Fever and fever of unknown origin: review, recent advances, and lingering dogma. Open Forum Infect Dis. 2020;7:ofaa132.CrossRef
Metadata
Title
Development of a risk prediction model for bloodstream infection in patients with fever of unknown origin
Authors
Teng Xu
Shi Wu
Jingwen Li
Li Wang
Haihui Huang
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2022
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-022-03796-8

Other articles of this Issue 1/2022

Journal of Translational Medicine 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.